p53 and breast cancer

A. M. Thompson

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

The p53 gene is commonly abnormal in sporadic breast cancer. Loss of normal p53 tumour suppressor function has been implicated in up to 61% of breast cancers and mutated p53, which may behave as an oncogene, has been directly demonstrated in 15-46%. These events affecting p53 may occur early in breast carcinogenesis, but also correlate with poor prognostic features in invasive breast cancer. Abnormalities of the p53 gene are common and could be key events in the pathogenesis of breast cancer.

Original languageEnglish (US)
Pages (from-to)8-10
Number of pages3
JournalThe Breast
Volume2
Issue number1
DOIs
StatePublished - Mar 1993

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'p53 and breast cancer'. Together they form a unique fingerprint.

Cite this